Clinical evaluation of Unani ointment in low backache

Evaluation of the efficacy and safety of topical Zimad-e-Muhallil for the management of low back pain (Waja’ al-Zahr) – A single blind randomized controlled trial. - UNACHE

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053202

Enrollment

Registered

2023-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M545- Low back pain

Interventions

Intervention1: Zimad-e-Muhallil: Zimad-e-Muhallil in the Form of Cream. Mode of application: Topical use over the lumbosacral region. Dosage: Quantity sufficient. Follow up: 7th and 14th day along wi

Eligibility

Inclusion criteria

Inclusion criteria: Low back pain Willing and able to participate in the trial as an outpatient and comply with all trial requirements.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women. Unstable, Bed-ridden and mentally retarded patients. Low back pain due to trauma and disc bulge/prolapse. Patients with history or presence of gout and rheumatoid arthritis. Patients with past history of spine surgery. Patient having any systemic illnesses. Immunocompromised patient.

Design outcomes

Primary

Measure	Time frame
Change in Modified Oswestry Low Back Pain Disability Questionnaire. Change in Core Outcome Measures Index (COMI) Back. Timepoint: At baseline and after trial completion	—

Secondary

Measure	Time frame
Change in overall disease severity on 100mm VASTimepoint: At baseline and after trial completion	—

Countries

India

Contacts

Public ContactDr Nazim Husain

Luqman Unani Medical College Hospital and Research Centre

dr.nazimhusain@gmail.com9212143572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026